Cellectis (CLLS) Receivables (2013 - 2026)
Cellectis' Receivables came in at $5.08 million for Q2 2026, down 42.2% from $8.78 million a year earlier and down 1.5% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Receivables (2013 - 2026) Analysis & Trends
At the end of FY2025, Cellectis' Receivables was $27.18 million, up 112.9% from FY2024.
- Receivables has increased in each of the last three years, with a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
- Going back by year, Receivables was $12.77 million in FY2024 (+75.3%), $7.28 million in FY2023 (+843.4%), $772,000 in FY2022 (-96.2%) and $20.36 million in FY2021 (+293.8%).
- The Q2 2026 figure represents the lowest quarterly Receivables since Q3 2023.
- Year-over-year, Receivables increased in two of the last seven quarters, with growth averaging 3.2%.
- The fastest year-over-year change in Receivables over five years came in Q4 2023 (growth of 843.4%), and the weakest in Q4 2022 (a decline of 96.2%).
- Business Quant data shows CLLS's Receivables at $5.15 million (Q1 2026), $27.18 million (Q4 2025) and $8.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Cellectis | 98.28 Mn | -655.11 Mn | - | 5.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Sep 30, 2025 | 8.06 Mn |
| Jun 30, 2025 | 8.78 Mn |
| Mar 31, 2025 | 7.87 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | 11.18 Mn |
| Jun 30, 2024 | 9.74 Mn |
| Mar 31, 2024 | 16.04 Mn |
| Dec 31, 2023 | 569,000.00 |
| Sep 30, 2023 | 393,000.00 |
| Jun 30, 2023 | 422,000.00 |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 772,000.00 |
| Sep 30, 2022 | 802,000.00 |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 21.84 Mn |
| Dec 31, 2021 | 20.39 Mn |
| Sep 30, 2021 | 349,000.00 |
API Access
Cellectis Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();